ketamine and postoperative pain management

EFFECT OF 0.25MG/KG INTRAVENOUS KETAMINE DURING SPINAL ANAESTHESIA ON POST CAESAREAN ANALGESIC REQUIREMENT IN ELECTIVE CAESAREAN SECTIONS IN MULAGO, A RANDOMIZED CLINICAL TRIAL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201404000807178

Enrollment

Registered

2014-04-03

Start date

2014-04-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery Postoperative pain Anaesthesia

Interventions

ketamine

placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ¿ Informed and consenting patients ¿ All Pregnant mothers scheduled for elective caesarean section under spinal anaesthesia ¿ ASA 1 and ASA 2

Exclusion criteria

Exclusion criteria: ¿ Hypertensive disorders ¿ Known clearly documented allergy to the study medication ¿ History of psychiatric disorders(hallucinations) ¿ Chronic opioid therapy ¿ Sickle cell disease ¿ Epilepsy ¿ Emergency obstetric cases ¿ Conversion to general anaesthesia

Design outcomes

Primary

Measure	Time frame
The time to breakthrough pain experienced by the patients in the first 24 hours following caesarean section delivery;The time to breakthrough pain experienced by the patients in the first 24 hours following caesarean section delivery	—

Secondary

Measure	Time frame
Numeric pain score at break through pain Total analgesia requirement in the 24 hours	—

Countries

Uganda

Contacts

Public ContactJOHNMARK KASUMBA

CONSULTANT

drkasmaya@gmail.com0793625678

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026